An oncogene-induced DNA damage model for cancer development

Thanos D Halazonetis1, Vassilis G Gorgoulis, Jiri Bartek

  • 1Department of Molecular Biology and Department of Biochemistry, University of Geneva, CH-1205 Geneva, Switzerland. Thanos.Halazonetis@molbio.unige.ch

Science (New York, N.Y.)
|March 8, 2008
PubMed

Insights

Activated oncogenes cause DNA double-strand breaks (DSBs), leading to genomic instability in precancerous lesions and cancers. Impaired DNA damage response pathways, often via p53 mutations, allow cancer development.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Genetics

Background:

  • DNA double-strand breaks (DSBs) are a significant cellular challenge.
  • Activated oncogenes in precancerous lesions and cancers induce replication fork stalling and collapse, forming DSBs.
  • DSBs are implicated in the genomic instability characteristic of most human cancers.

Purpose of the Study:

  • To investigate the role of oncogene-induced DNA damage in cancer development.
  • To explore the connection between DNA double-strand breaks, genomic instability, and p53 pathway alterations in cancer.

Main Methods:

  • Experimental analysis of DNA damage response in precancerous lesions and cancers.
  • Investigation of oncogene-induced replication stress.
  • Assessment of p53 activation and its role in tumor suppression.

Main Results:

  • Activated oncogenes continuously generate DNA double-strand breaks (DSBs).
  • These DSBs contribute to genomic instability observed in cancers.
  • DSBs activate p53, acting as a barrier to tumor progression, but this barrier is often overcome by p53 mutations.

Conclusions:

  • Oncogene-induced DNA damage is a key driver of cancer's genomic instability.
  • The p53 pathway's role in responding to DSBs is crucial for preventing cancer.
  • Frequent p53 mutations facilitate cancer development by impairing the DNA damage response.

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...